Evidence method
Sequential · gp.financial.deposits
-5.68% · CORE · VALID
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
BRBS · Jun 30, 2024
BLUE RIDGE BANKSHARES, INC.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0000950170-24-091820Bank
Evidence method
Yoy · gp.financial.interest_expense
10.64% · CORE · VALID
Evidence method
Yoy · gp.financial.interest_income
-4.31% · CORE · VALID
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History21 statesSelf-history eligible
Dec 31, 20200/5 normalizedLevel 3Mar 31, 20210/5 normalizedLevel 3Jun 30, 20210/5 normalizedLevel 3Sep 30, 20210/5 normalizedLevel 3Dec 31, 20212/5 normalizedLevel 3Mar 31, 20222/5 normalizedLevel 3Jun 30, 20222/5 normalizedLevel 3Sep 30, 20225/5 normalizedLevel 3Dec 31, 20225/5 normalizedLevel 3Mar 31, 20235/5 normalizedLevel 3Jun 30, 20235/5 normalizedLevel 3Mar 31, 20235/5 normalizedAmended as filedJun 30, 20235/5 normalizedAmended as filedSep 30, 20235/5 normalizedLevel 3Dec 31, 20225/5 normalizedAmended as filedDec 31, 20235/5 normalizedLevel 3Mar 31, 20245/5 normalizedLevel 3Jun 30, 20243/3 normalizedLevel 3Sep 30, 20253/3 normalizedLevel 3Jun 30, 20263/3 normalizedLevel 4
Period transition
What moved in the state?
- Previous
- -3.91%
- Current
- -5.68%
- Delta
- -1.77%
- Previous
- 41.34%
- Current
- 10.64%
- Delta
- -30.70%
- Previous
- 4.01%
- Current
- -4.31%
- Delta
- -8.32%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.